TCT 2024 – ACCESS-TAVI: Comparing Percutaneous Access Closure Strategies After TAVI

Vascular access complications following transcatheter aortic valve implantation (TAVI) remain common. However, few studies compare vascular access closure methods. 

TCT 2024 | Utilización de balones cubiertos de fármacos para el tratamiento de la rama lateral en técnica de stent provisional

Based on the CHOICE-CLOSURE and MASH studies, double ProGlide use was associated with fewer access complications than the Manta device. Consequently, the former became the most accepted therapeutic option.

The ACCESS-TAVI study included patients with severe aortic stenosis scheduled for transfemoral TAVI, randomly assigned (1:1) to suture-and-plug closure (ProGlide and Angio-Seal) or suture-only closure (double ProGlide).

The primary objective was assessing a composite of major or minor vascular access-related complications (VARC-3 criteria) during hospitalization. Ultrasound-guided puncture was recommended, while secondary access was used at the operator’s discretion.

A total of 454 patients were included. Their average age was 80 years; 51.7% of subjects were women, and 11.3% had peripheral arterial disease. Among patients, 49.6% had no calcification, 21.9% had mild calcification, and 97% showed mild or no tortuosity. Ultrasound-assisted puncture was used in 57.8% of cases, and the right transfemoral access was the preferred choice (88.7%). A secondary transradial access was used in 40.9% of cases.

Read also: TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions.

In the analysis of the primary endpoint, vascular complications, the suture/plug group had 27% events vs 54% in the suture-only group, with a relative risk [RR] of 0.55 (95% confidence interval [CI]: 0.44-0.68; P ≤0.001). Reduced events were mainly due to fewer minor vascular complications and bleeding grade ≥ 2.

The authors concluded that the use of suture-and-plug closure reduces vascular complications compared with suture-only closure and is associated with shorter time to hemostasis.

Presented by Tobias A. Rheude in the Late-Breaking Trials Sessions, TCT 2024, October 27-29, Washington, USA.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...